{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T15:39:00Z","timestamp":1705419540682},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. &amp; Tumor Pharmacother."],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf02985235","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"source":"Crossref","is-referenced-by-count":2,"title":["Specificity of tumor markers (CEA, GICA, TPA, \u03b1-FP, FpA, \u03b3-GT) for the diagnosis of hepatic metastases from large bowel cancers"],"prefix":"10.1007","volume":"6","author":[{"given":"Vincenzo","family":"Abbasciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Levato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Zavagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02985235_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF02586558","volume":"21","author":"F F Attiyeh","year":"1978","unstructured":"Attiyeh F F, Wanebo H J, Stearns M W: Hepatic resection for metastasis from colorectal cancer.Dis Colon Rectum\n                           21, 160 (1978).","journal-title":"Dis Colon Rectum"},{"key":"BF02985235_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000658-198005000-00009","volume":"191","author":"M A Adson","year":"1980","unstructured":"Adson M A, van Heerden J A: Major hepatic resections for metastatic colorectal cancer.Ann Surg\n                           191, 576 (1980).","journal-title":"Ann Surg"},{"key":"BF02985235_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/1097-0142(197908)44:2<414::AID-CNCR2820440207>3.0.CO;2-3","volume":"44","author":"R A Oberfield","year":"1979","unstructured":"Oberfield R A: Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary cancer.Cancer\n                           44, 414 (1979).","journal-title":"Cancer"},{"key":"BF02985235_CR4","first-page":"1","volume":"8","author":"V Abbasciano","year":"1985","unstructured":"Abbasciano V, Levato F, Gullini S, Pollinzi V, Buccoliero F, Bagni B, Boccia S, Bertusi M: Studio di un protocollo di markers per i tumori del tratto gastroenterico: utilit\u00e0 clinica, diagnostica e prognostica (AFP, beta-HCG, CEA, ferritina, GICA, TPA, FpA).Riv Oncol\n                           8, 1 (1985).","journal-title":"Riv Oncol"},{"key":"BF02985235_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/1097-0142(19810901)48:5<1242::AID-CNCR2820480531>3.0.CO;2-Q","volume":"48","author":"M Koch","year":"1981","unstructured":"Koch M: CEA levels as an indicator of the primary site in metastatic disease of unknown origin.Cancer\n                           48, 1242 (1981).","journal-title":"Cancer"},{"key":"BF02985235_CR6","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1136\/bmj.286.6380.1824","volume":"286","author":"K R Hine","year":"1983","unstructured":"Hine K R: CEA in disseminated colorectal cancer.Br Med J\n                           286, 1824 (1983).","journal-title":"Br Med J"},{"key":"BF02985235_CR7","first-page":"129","volume":"35","author":"V Abbasciano","year":"1983","unstructured":"Abbasciano V, Arcadi A, Abbasciano N, Pittini S, Pollinzi V: Antigene carcinoembrionario (CEA) e tissue polypeptide antigen (TPA) nella patologia neoplastica e non del tratto gastroenterico.Riv Gastroent\n                           35, 129 (1983).","journal-title":"Riv Gastroent"},{"key":"BF02985235_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.6163212","volume":"212","author":"H Koprowski","year":"1981","unstructured":"Koprowski H, Herlyn J, Steplewski Z, Sears H F: Specific antigen in serum of patients with colon carcinoma.Science\n                           212, 53 (1981).","journal-title":"Science"},{"key":"BF02985235_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00916898","volume":"2","author":"H Sears","year":"1982","unstructured":"Sears H, Herlyn J, Del Villano B C, Steplewski Z, Koprowski H: Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longituclinal evaluation of patients with colorectal cancer.J clin Immun\n                           2, 141 (1982).","journal-title":"J clin Immun"},{"key":"BF02985235_CR10","first-page":"9","volume":"1","author":"B Bj\u00f8rklund","year":"1980","unstructured":"Bj\u00f8rklund B: On the nature and clinical use of tissue polypeptide antigen (TPA).Tumor Diagnost\n                           1, 9 (1980).","journal-title":"Tumor Diagnost"},{"key":"BF02985235_CR11","first-page":"117","volume":"2","author":"A Skyten","year":"1981","unstructured":"Skyten A, Unsgaard B, Bj\u00f8rklund B, Eklund G: Serum TPA related to activity in a wide spectrum of cancer conditions.Tumor Diagnost\n                           2, 117 (1981).","journal-title":"Tumor Diagnost"},{"key":"BF02985235_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(74)91842-X","volume":"2","author":"R Masseyeff","year":"1974","unstructured":"Masseyeff R, Rey J F, Cossuto J P, Krebs B, Delmont J: Radioimmunoassay of alpha fetoprotein in gastrointestinal disease.Lancet\n                           2, 461 (1974).","journal-title":"Lancet"},{"key":"BF02985235_CR13","first-page":"3","volume":"96","author":"F W Peuscher","year":"1980","unstructured":"Peuscher F W, Cleton F J: Significance of plasma FpA in patients with malignancy.J Lab clin Med\n                           96, 3 (1980).","journal-title":"J Lab clin Med"},{"key":"BF02985235_CR14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0038-1653457","volume":"46","author":"Y Yoda","year":"1981","unstructured":"Yoda Y: Fibrinopeptide A (FpA) level and fibrinogen kinetics in patients with malignant disease.Thromb Haemost\n                           46, 706 (1981).","journal-title":"Thromb Haemost"},{"key":"BF02985235_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02934943","volume":"4","author":"V Abbasciano","year":"1987","unstructured":"Abbasciano V, Levato F, Zavagli G: Specificity of fibrinopeptide A (FpA) as a marker for gastrointestinal cancers before and after surgery.Med Oncol Tumor Pharmacother\n                           4, 75 (1987).","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"BF02985235_CR16","first-page":"117","volume":"2","author":"V Abbasciano","year":"1984","unstructured":"Abbasciano V, Levato F, Pollinzi V: Sul significato clinico-diagnostico della gamma-glutamiltransferasi sierica (SGGT) in confronto col CEA nella patologia primitiva e metastatica epatica del tratto gastroenterico.Riv Oncol\n                           2, 117 (1984).","journal-title":"Riv Oncol"},{"key":"BF02985235_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-88-5-627","volume":"88","author":"A Shani","year":"1978","unstructured":"Shani A, O\u2019Connell M J, Moertel C G, Schutt A J, Silvers A, Go V L W: Serial plasma measurement of carcinoembryonic antigen in the management of metastatic colorectal carcinoma.Ann intern Med\n                           88, 627 (1978).","journal-title":"Ann intern Med"},{"key":"BF02985235_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/030089167406000308","volume":"60","author":"A Azzopardi","year":"1974","unstructured":"Azzopardi A: The diagnostic significance of serum alpha fetoprotein.Tumori\n                           60, 231 (1974).","journal-title":"Tumori"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02985235\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:17:16Z","timestamp":1631906236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02985235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF02985235"],"URL":"https:\/\/doi.org\/10.1007\/bf02985235","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1989,6]]},"article-number":"129"}}